Design Therapeutics (DSGN) Non-Current Assets (2020 - 2026)

Design Therapeutics (DSGN) has 7 years of Non-Current Assets data on file, last reported at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 11.43% year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $11.6 million (down 31.54% YoY), and the FY2025 full-year result was $2.4 million, down 40.32% from the prior year.
• Non-Current Assets rose to $3.4 million in Q1 2026, from $2.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $6.2 million in Q2 2022 to a low of $2.4 million in Q4 2025.
• A 5-year average of $4.6 million and a median of $4.9 million in 2024 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets surged 4830.0% in 2022 and slumped 40.32% in 2025, its largest moves.
• Tracing DSGN's Non-Current Assets over 5 years: stood at $6.0 million in 2022, then declined by 15.94% to $5.1 million in 2023, then retreated by 19.89% to $4.1 million in 2024, then tumbled by 40.32% to $2.4 million in 2025, then soared by 40.26% to $3.4 million in 2026.
• Business Quant data shows DSGN's Non-Current Assets at $3.4 million in Q1 2026, $2.4 million in Q4 2025, and $2.7 million in Q3 2025.